H2020 IMI: Apertura convocatoria urgente Coronavirus
Presupuesto: 45 M€ de financiación pública. La contribución de EFPIA y miembros asociados de IMI, se determinará en función de las propuestas seleccionadas.
Se trata de una convocatoria de una sola fase, con un único topic:
• Development of therapeutics and diagnostics combatting coronavirus infections
Scope: Considering that this is a newly-identified virus, the scope of this topic remains broad and must address at least one of the following objectives:
• development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak;
• development of therapeutics to address the current and/or future coronavirus outbreaks;
• development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies;
• development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection.